Is there a link between breast cancer and abortion? This is the first of I've heard of it -- and I consider myself fairly well-versed in the topic of breast cancer. Maybe I missed a beat somewhere along the line.

Think about this:

There is a Coalition on Abortion/Breast Cancer out there and Karen Malec, head of the group, says there would be far fewer breast cancer cases and deaths if women had been told the truth in the 1980s when conclusive evidence linked abortion with the disease.

Malec reports that government scientists wrote a letter in 1986 to the British journal Lancet, acknowledging that abortion causes breast cancer. She says as of 2006, eight medical organizations had recognized abortion as one cause of the disease.

Now this has nothing to do with delaying pregnancy until later in life -- also a known risk factor. Abortion stands on its own and is problematic because carrying a pregnancy to term is what protects against breast cancer, says Malec.

The American Cancer Society (ACS) does not agree and stands behind several studies backed by strong data concluding induced abortions have no overall effect on the risk of breast cancer.

Malec says such studies are seriously flawed.

"We call on the Society and other cancer businesses to put their priorities in order," she says. "Women's lives and cancer prevention are more important than making money, doing cancer walks, and protecting the abortion and pharmaceutical industries."

Malec also condemns Susan G. Komen For the Cure for donating money to Planned Parenthood -- a group she calls the nation's leading abortion business.

"It's unthinkable that groups that claim to want to eradicate the disease would help fund a cancer-causing organization, especially when the funds could be directed to legitimate health organizations."

Unthinkable? I'm not sure.

I need to think about it.

White House Press Secretary Tony Snow popped in for an unexpected visit on Bill O'Reilly's Radio Factor on Wednesday with the purpose of clearing up a certain cancer matter.

"Some of this has been misreported," Snow told O'Reilly in reference to his recent cancer recurrence.

"I do not have liver cancer," Snow said. "There are a number of small tumors that are in my abdominal cavity; they have not hit any other organs."

Snow, 51, said there is also no cancer traveling through his bloodstream and that he plans to return to work after recovering from the surgery he had two weeks ago to remove tumors from his abdomen.

Although his cancer is not threatening his life -- he says if the tumors didn't grow from now until the time he died, he would be absolutely fine -- Snow will still receive chemotherapy to "drive this sucker into remission," he said.

Snow began battling cancer in 2005 when he was diagnosed with colon cancer, had his colon removed, and underwent several months of chemotherapy.

One out of three Americans will get cancer before they die. Who is at the highest risk?

Dr. David Nanus, an oncologist who has been treating cancer patients for over twenty years, says that "If you're obese or overweight, you have an increased incidence in a number of cancers". Nanus also tells CBS news that someone with a family history, someone who smokes, has a high fat diet and does not exercise are in the highest risk category for developing cancer in their lifetime.

According to the American Cancer Institute about one third of cancer deaths in 2006 were related to nutrition, physical inactivity and being overweight or obese -- and could have been prevented.

Nanus also says that "The biggest problem is the fear factor. People are so afraid of being diagnosed with cancer they wait. Even waiting three months can mean a difference between life and death.

An independent report revealed recently that women employed at the Toowong site of ABC's former Brisbane studios in Australia were six times more likely to develop breast cancer than other women.

The site has been vacated. And the hunt is on -- for the cause of this unusually high rate of the disease.

No luck yet -- but new findings, while not definitive on what has caused this cluster, do indicate exposure to electromagnetic fields (EMF) is not a factor -- because the low frequency fields at the site were typical of other workplaces and residences, without any such cancer cluster.

Further testing will take place in an attempt to solve this on-going mystery, chronicled in the posts that follow.

ABC journalists walk out over cancer cluster concerns
Breast cancer cluster closes ABC studios in Australia
Connecting the clues in Australia cancer cluster

The old saying an aspirin a day keeps the doctor away seems to apply for certain cancers now. Researchers reported that aspirin and other NSAIDs decrease the risk of progression of the most aggressive form of Barrett's esophagus to esophageal cancer. In a study NSAID users took the drug at least once a week for six or more months any time during follow-up, regardless of daily frequency, duration, or type, the researchers reported. Galipeau and colleagues also found that those with three or more of the biomarkers who used aspirin or other NSAIDs had a 30% risk of esophageal cancer after 10 years, while those with the same biomarkers who did not use NSAIDs had a 79% risk of developing cancer within a decade.

The vast majority of patients in this cohort had gastroesophageal reflux disease and were undergoing therapy, mainly with proton-pump inhibitors. It is unclear how the frequency or severity of symptoms may have affected NSAID use by participants, the researchers said. However, to their knowledge, they said, symptoms from reflux are not associated with intermediate endpoints or cancer in Barrett's esophagus, so it is unlikely that symptoms could explain the association of NSAID use with reduced risk of esophageal cancer. The findings may help identify patients who may benefit most from a very cost-effective, noninvasive therapy in the form of aspirin or NSAIDS.

A study appearing in the Journal of Clinical Oncology reveals there may be something out there that can extend the lives of patients with recurrent prostate cancer.

This something is a new class of anti-cancer targeted drugs that scientists at Cedars-Sinai Medical Center in Los Angeles say are quite promising, despite their ineffectiveness in some prostate cancer patients with no previous chemotherapy treatment.

Pertuzumab, a molecular targeted compound that has been used successfully in ovarian cancer patients, has been shown to block the human epidermal growth factor receptor family by binding to and inhibiting the function of HER2 receptors. They essentially block a key pathway that leads to cancer growth. And this blockage can possibly offer a better, longer life for recurrent prostate cancer patients whose diseases no longer respond to traditional chemotherapy.

Pertuzumab, marketed under the brand name Omnitarg by Roche and Genentech, is just one of many targeted cancer therapies that give researchers hope that cancer may one day be a lifetime disease that can be skillfully managed.

Chemotherapy sent my blood counts spiraling on two separate occasions. Both times I landed in the hospital. And during my second stay, it took several daily injections of Neupogen -- a growth factor immunity drug -- to push my white blood counts from a low 1,200 to a whopping 58,000.

The only side effect I suffered as a result of this drug was aching bones and joints. This was temporary and not such a big deal. What might be a big deal for breast cancer survivors like me, however, is the result of a new study suggesting there may be a risk of leukemia from these immunity boosting drugs.

These drugs, G-CSF (such as Neupogen) and GM-CSF (such as Leukine) may cause rare cases of leukemia, says Columbia University's Dawn Hersmand whose study is published in yesterday's Journal of the National Cancer Institute.

It's already been established that chemotherapy itself can cause leukemia. And Hersmand's study showed 1.04 percent of women who did not receive growth factors developed leukemia from chemotherapy alone. But 1.77 percent of women treated with G-CSF or GM-CSF developed the disease. While the drugs appear to statistically double the risk, the actual risk still remains quite small. And researchers say the benefits of the drug right now outweigh the risks.

A drug commonly used to minimize the toxic effects of chemotherapy has been shown in mice to cause bone loss and promote tumor growth, according to the results of a recent study.

This drug, granulocyte colony-stimulating factor (G-CSF) -- also known as Neupogen, Neulasta, and Granocyte -- helps restore white blood cell counts that take a beating during chemotherapy, protecting cancer patients from an increased risk of infection.

According to researchers, G-CSF -- essentially a growth factor -- encourages bone breakdown. And any therapy that decreases bone density can enhance tumor growth in bones. So doctors are urged to closely monitor their patients during chemotherapy with regular bone density scans. They can also prescribe medications to prevent bone loss if necessary. And patients can protect their bones by consuming enough calcium and vitamin D and engaging in regular exercise.

Currently, research on cancer patients treated with G-CSF have not yielded the same strong results researchers found among mice.

The details of this study appear online in the journal Blood, and will be published in an upcoming print issue.

I have dense breasts. And ever since the surgeon who performed my breast reduction surgery more than 10 years ago told me about the composition of my breast tissue, I have been a bit obsessed with how my breasts feel. Good thing -- because I ended up with breast cancer two years ago as a result of my own at-home monitoring. And now I wonder if my cancer was influenced by the density characterizing the tissue that fills my breasts.

Canadian researchers are reporting in a groundbreaking study that women with dense breasts, like me, are five times more likely to develop breast cancer than whose whose breasts have a lot of fatty tissue. It's long been knows that dense breasts inhibit the effectiveness of X-ray mammograms -- and perhaps delay diagnosis -- but now it's clear that breast density is a risk factor all on its own.

Evangelical preacher Darlene Bishop believes prayer can cure cancer. She wrote a book about it, and she convinced her brother to abandon conventional cancer treatment so he could fully pursue the power of prayer. Sadly, his pursuits were unsuccessful and he died 18 months ago from throat cancer. Now Bishop is in the midst of a multi-faceted legal battle with family members who claim she did her brother wrong. Maybe she did.

Perhaps prayer alone can't cure cancer, but a new study does indicate prayer can be of great benefit to some people following a cancer diagnosis.

Researchers at the University of Wisconsin looked at transcripts from 97 breast cancer patients active in an on-line support group. They found patients who wrote more religious words -- like prayer, worship, faith, and holy -- had less negative emotions than other patients. They also had higher levels of overall well-being.

This study, also revealing prayer has the same effect regardless of specific religious practices, lends support to research showing cancer patients with positive purpose in their lives fare better through their journeys than those floundering in negativity.

Smoking is the biggest risk factor for lung cancer -- and 90 percent of all lung cancer cases are related to smoking. But family history is a risk factor too and can nearly double the risk of developing the deadly disease.

A study published in the October issue of Chest found by studying a population of Japanese adults that people with a first-degree relative -- mother, father, or sibling -- who had lung cancer had a 95 percent higher risk of contracting the disease. Those who smoked had the greatest risk, but those who did not smoke were still at risk. And women were more at risk than men. The type of lung cancer most associated with family history is squamous cell carcinoma.

The results of this study do not yet translate into recommended guidelines for screening. But those with a family history of lung cancer should make their physicians aware of their history. And perhaps one day people with family history will be identified as high-risk for lung cancer and will be included in further studies. In the meantime, these individuals should avoid all contact with all inhaled and second-hand smoke and should protect their children from all forms of tobacco smoke.

The U.S. Centers for Disease Control and Prevention estimates that more than 180,000 cases of lung cancer are diagnosed each year. About 170,000 die from the disease every year. It's the second leading cause of death for men and the third leading cause of death for women.

It's day 15 in this Breast Cancer Awareness Month and the survivors spotlighted on this site are stacking up. Yet we've only just scratched the surface of breast cancer survivor stories. And by the end of October, we will have only featured a very small sample of survivors everywhere. There are countless others with their own powerful stories. It's sad there are so many stories shaped by breast cancer. It's empowering too -- because breast cancer survivors are a passionate bunch. They are passionate in their fights, passionate in their beliefs, passionate in their willingness to help others.

A passionate bunch of survivors can be found here on The Cancer Blog. They are all women, of various ages, with various backgrounds, defined by different experiences. They are also quite the same -- for they have all been touched by breast cancer. And their words of wisdom are strikingly similar, despite the contrast in characteristics that define these women and their very individual battles with breast cancer.

Here are seven survivor similarities worth spotlighting.

In the United States, mammograms are not recommended for women under the age of 40. Other then an annual check-up and a monthly self breast exam, young women with no family history of breast cancer have no medical tools available for preventing and detecting the disease. But no woman is immune to this disease -- and being female is the single most important risk factor for diagnosis. And young women do get breast cancer. I did. And so did Sharon Rutherford, a 36-year-old Ulster woman who was diagnosed in December.

Rutherford is urging health officials to lower the age for screening in Northern Ireland -- where routine breast screening programs are reserved for women between the ages of 50 and 64. Rutherford says this is inadequate as there is an "absolutely chronic" number of younger women suffering from breast cancer.

Although there is a reduced-age screening program that monitors women beginning at age 40, Rutherford would like to see the screening age reduced to 30. Until then, she is educating women about how they can be vigilant about their own care. She urges women to report to doctors anything that just doesn't feel right. And because doctors may excuse symptoms because women are "too young" for breast cancer -- that's what doctors told her -- women must aggressively pursue medical care. Rutherford kept pursuing the thickening she felt in her breast -- and eventually she was referred for screening.

Rutherford has had a partial mastectomy, chemotherapy, and radiation treatment. And she is now active in the Ulster Cancer Foundation's new support group -- specifically for women under the age of 40.

Studies exist that link acid-reflux conditions to cancer of the larynx -- or voice box -- but authors of a new study say they all suffer shortcomings in methodology.

The new study, published in the American Journal of Medicine, was intended to make up for these shortcomings by comparing 96 men and women with laryngeal cancer to a group of adults without the disease. All participants were matched by age, gender, and ethnicity -- three of the most important risk factors for this cancer. Overall, the study found people with GERD -- gastroesophageal reflux disease -- were twice as likely to develop laryngeal cancer, compared to those without the condition. GERD has long been considered a possible risk factor for this cancer, mostly because GERD is common among people with the cancer. More definitive studies are on the horizon.

GERD, which occurs when the muscle of the bottom of the esophagus fails to close properly, allowing stomach acids to leak into the esophagus, is also linked to esophageal cancer.